It was a busy week in the biotech sector with lots of regulatory and pipeline updates. Among bigwigs, Gilead Sciences, Inc.

GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug conjugate (ADC), GSK’227 has gained priority medicines (PRIME) ...

GSK PLC GSK shares rose 1.06% to £13.34 Tuesday, on what proved to be an all-around dismal trading session for the stock ...

For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief digital and technology officer ...

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

Shares of GSK PLC GSK inched down 0.75% to £13.20 Monday, on what proved to be an all-around grim trading session for the ...

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

Biogen (BIIB) closed near a 52-week low of $150.03. The stock trades at a discount because the biotech firm lacks growth ...

进口二价HPV疫苗希瑞适是目前唯一采用创新佐剂系统的HPV疫苗，旨在为适龄女性提供健康保护。去年5月9～14岁女孩的两剂次接种程序获批，将预防先行落在实处，助力推进我国消除宫颈癌行动及目标的早日实现。

GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

Dr. Gur Levy, Respiratory Medical Expert at GSK, said, "We have been pioneering efforts for decades to develop new ...